Market Context — Why This Technology, Why Now

The global shift towards ethical and sustainable research practices, coupled with increasing consumer demand for healthier, personalized, and plant-based food options, is creating immense pressure on R&D. This technology offers a critical solution by providing a high-fidelity, animal-testing-alternative for taste evaluation, enabling companies to innovate faster, reduce costs by ~50% compared to primate studies, and meet evolving regulatory and consumer expectations worldwide.

Key Competitive Advantages
01

Replicates human-specific taste responses with high precision in vitro, improving development success rates.

02

Accelerates screening cycles by eliminating ethical reviews and animal husbandry, potentially shortening time-to-market by up to 30%.

03

Reduces equipment, husbandry, and personnel costs by ~50% compared to primate animal testing, supporting ESG initiatives.

Market Opportunity
Food & Beverage
$3B–$4B globally (AI est.)
Rapidly expanding taste evaluation needs for health-conscious and diverse food cultures, including reduced-salt/sugar, alternative foods, and functional foods.
Major food manufacturers Beverage innovation labs Alternative protein developers Flavor and ingredient suppliers
Pharmaceuticals & Supplements
$1.5B–$2.5B globally (AI est.)
Broad needs exist from drug discovery to clinical application, including drug taste masking, evaluating taste changes due to side effects, and drug selection for personalized medicine.
Pharmaceutical R&D divisions Nutraceutical and supplement companies Contract research organizations (CROs) Personalized medicine developers
Cosmetics & Personal Care
$1B–$2B globally (AI est.)
Growing demand for high-precision, animal-testing-alternative evaluation systems for oral care products, fragrances, and ingredient taste/sensory assessment.
Oral care product manufacturers Cosmetic ingredient suppliers Fragrance and flavor houses Personal care product developers
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a specific method for culturing primate-derived taste bud organoids and their use in screening taste substances, including defined culture protocols and media compositions. The claims are considered robust due to successfully overcoming examiner objections, indicating high novelty and a clear scope of protection.

Competitive White Space

This patent primarily covers primate taste bud organoid culture and taste substance screening. White space exists in developing organoids from other species, exploring non-taste related applications like toxicology, or integrating the organoids into advanced drug delivery systems.

Economic Impact
~$1M/year estimated R&D cost reduction per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

By replacing primate animal testing, this technology could reduce annual animal husbandry and management costs by ~$350K (AI est.) and researcher personnel costs by ~$200K (AI est.). Additionally, shortening the development period by 1.5 years could generate an estimated ~$450K/year (AI est.) in avoided opportunity costs from earlier market entry. Total potential R&D cost reduction is up to ~$1M/year (AI est.).

Speed to Market
8× faster than in-house development
Developing this technology from scratch in-house could take 5-7 years to establish primate cell acquisition, organoid culture protocols, and functional evaluation systems. However, licensing this patent allows for deployment in approximately 0.5-1 year, including optimization, as primate-derived taste bud organoid culture protocols are already established and specific media compositions are detailed. Eliminating ethical review processes for animal testing also enables rapid evaluation from early development stages, significantly shortening time-to-market.
Competitive Positioning

X: Human Taste Replicability
Y: R&D Efficiency

Business Models & Applications
🔬 Evaluation Services
Licensees can leverage this technology to offer in vitro taste substance evaluation services to food, pharmaceutical, and cosmetic manufacturers, establishing a new revenue stream by providing high-precision data.
🤝 Collaborative R&D
Engage in collaborative research on specific food ingredients or drug candidates, focusing on taste improvement or side effect evaluation. This combines the technology's insights with the licensee's product development capabilities to create innovative products.
📝 Technology Licensing
By obtaining a license to this patent, companies can freely utilize this technology for their own product development, enhancing R&D efficiency and securing a technological advantage over competitors.
Adjacent Application Opportunities
🧪 Drug Discovery & Healthcare
Taste Disorder Drug Screening
Utilize taste organoids to elucidate mechanisms of taste disorders caused by aging or disease, and efficiently screen drug candidates with improving effects. This could enable applications in personalized medicine.
🐶 Pet Food
Pet Food Palatability Assessment
Applying this technology to culture taste bud organoids from other animal species (e.g., dogs or cats) could enable in vitro evaluation of pet food palatability and taste improvement effects. This accelerates product development while reducing animal testing.
🌿 Vertical Farming & Alternative Proteins
Alternative Food Taste Enhancement
This platform could be used to analyze and evaluate the unique flavors (off-flavors) of emerging foods like plant-based meats and cultured meat, identifying optimal ingredients and manufacturing methods for taste improvement.
Integration Roadmap — Estimated 18-Month Deployment
Phase 1: Technology Transfer & Protocol Optimization
Duration: 3 months
Introduce the patent's culture protocol and media composition, adjusting it to the licensee's lab environment to establish stable taste bud organoid production conditions. Conduct initial verification and define quality control standards.
Phase 2: Screening System Setup & Pilot Evaluation
Duration: 6 months
Construct a taste substance screening system using the produced taste bud organoids and evaluate system performance with standard taste substances. Confirm suitability for practical operation through pilot-scale evaluation.
Phase 3: Full-Scale Adoption & Application Expansion
Duration: 9 months
Fully integrate the established screening system into the company's R&D process for taste evaluation of new materials and drug candidates. Explore expansion into new application areas such as taste disorder research and palatability assessment.
Technical Feasibility
This technology's processes, including the crushing of circumvallate papilla cells, protease treatment, and culture with specific media components and basement membrane matrix as described in the claims, can be performed with standard cell culture equipment and commercially available reagents. Companies with existing bio research facilities or cell culture equipment can adopt it without significant capital investment, indicating a relatively low technical barrier. The clear establishment of protocols suggests a smooth technology transfer.
Success Scenario
Upon adopting this technology, the taste evaluation process for new materials and drugs could be shortened by approximately 30% compared to traditional animal testing. This could reduce time-to-market by 1.5 years, establishing a competitive advantage. Furthermore, obtaining taste data closer to human responses is expected to improve product development success rates, enabling the rapid introduction of innovative products that meet consumer needs.
Patent Record
APPLICATION NO.
JP2017-007181
REGISTRATION NO.
6889467
FILING DATE
2017/01/19
GRANT DATE
2021/05/25
EXPIRATION DATE
2037/01/19
PATENT HOLDER
学校法人東京農業大学
Examination History
2020-01-10
Request for Examination
2020-02-04
Invitation to Amend (Intermediate Document)
2020-04-01
Amendment (Voluntary)
2020-10-06
Office Action
2020-12-07
Amendment (Voluntary)
2020-12-07
Applicant's Response
2021-05-11
Decision to Grant